Full Breakdown
Cychlorphine: A New Synthetic Opioid Driving Overdose Deaths Across the United States
By Drooid · · How we work
Emergence and Recent Fatalities
Cychlorphine, a synthetic opioid in the “orphine” family, has appeared in illicit markets nationwide. Health officials link the compound to a growing tally of overdose deaths, beginning with a February fatality in Los Angeles County confirmed in October. Subsequent reports identify deaths in Tennessee, Illinois, California, Oklahoma and other states. The drug’s potency—estimated about ten times stronger than fentanyl—means minute quantities can cause respiratory failure and death.
Background & Context
The orphine class originated from pharmaceutical research in the 1960s-1970s, with recreational appearances recorded in 2020. Cychlorphine (also called N-propionitrile chlorphine) was first detected in the U.S. drug supply in 2024 and has been identified in 19 states. Its rise accelerated after the United Nations Office on Drugs and Crime (UNODC) reported that, following China’s 2025 class-wide control of nitazene opioids, detections of orphines—led chiefly by cychlorphine—began to increase.
Data & Statistics
- Tennessee officials reported more than 30 fatal overdoses linked to cychlorphine since October 2025; a White House notice later cited at least 41 Tennessee deaths between July 2025 and February 2026 and at least 55 deaths nationwide.
- The Center for Forensic Science Research and Education identified cychlorphine in 25 fatal-overdose blood specimens, being the sole opioid in 11 cases.
- NMS Labs has tentatively identified the drug in over 100 toxicology cases across nine U.S. states and three Canadian provinces.
- UNODC recorded 10 countries reporting cychlorphine, with 182 seizures and 78 related deaths.
Official Statements & Responses
- The White House Office of National Drug Control Policy warned of cychlorphine’s potency, its undetectability by standard test strips, and the potential need for multiple naloxone doses.
- The Drug Enforcement Administration placed cychlorphine in Schedule I in August 2026, making possession or distribution illegal.
- UNODC noted the drug appears in counterfeit Xanax, Percocet, Dilaudid and OxyContin, and that standard test strips are not calibrated to detect it.
- County health officials advise users never to use alone, start with a very small amount, avoid mixing with alcohol or sedatives, and carry naloxone, which may require several administrations.
On-the-Ground Reports
Los Angeles County confirmed its first cychlorphine-related death in February, followed by a second fatality in Northern California in April. Both incidents involved the drug mixed into pills, powders or liquids without the user’s knowledge. Local authorities have launched a free drug-checking program that can identify cychlorphine within 15–20 minutes, and naloxone nasal spray is available without prescription at community health stations.
Conflicting Reports & Gaps
Health officials assert that standard fentanyl test strips do not detect cychlorphine; the extent to which emerging proprietary strips might eventually do so remains unknown.
Verbatim Quotes
- “Sometimes, by talking about how potent some of these substances are, we increase the allure of them for some addicts, unfortunately,” — Nicholas Kardaras
- “What used to take one or two doses of Narcan to reverse an overdose may now require five or six doses, based on anecdotal evidence,” — Nicholas Kardaras
What’s Next
- The DEA’s Schedule I classification, effective August 2026, enables federal prosecution of possession and distribution.
- UNODC continues to monitor international seizures and deaths, with periodic alerts expected as new data emerge.
- Los Angeles County plans to expand its free drug-checking service and increase naloxone distribution through public health centers.
The convergence of extreme potency, detection challenges, and rising fatality counts positions cychlorphine as a pressing public-health threat that authorities across multiple jurisdictions are scrambling to address.
